Answer:
The correct answer is "True"
Explanation:
The responsibility for you developing into a marketplace Profesional falls primarily in your own shoulders.
Hybridomas, which produce monoclonal antibodies, are made by fusing cells of the immune system with B lymphocytes and myeloma cells.
<h3>
What are Hybridomas?</h3>
- Large-scale production of monoclonal antibodies is made possible through hybridoma technology.
- An antigen that triggers an immune response is first injected into a mammal to begin the process.
- A specific sort of white blood cell called a B cell makes antibodies that bind to the antigen that has been injected.
- These antibody-producing B-cells are then removed from the animal and combined with immortal B cell cancer cells, or myeloma, to create a hybrid cell line known as a hybridoma.
- It possesses both longevity and procreative capacity of the myeloma and the antibody-producing capacity of the B-cell.
Hence, the creation of hybridomas, which result in the production of monoclonal antibodies, involves fusing immune system cells with B lymphocytes and myeloma cells.
To learn more about Hybridomas refer to:
brainly.com/question/15189667
#SPJ4
Answer:
Immune modulators are the chemical agent that alters the immune system by stimulation or inhibition of the white blood cell activity.
Explanation:
A chemical agent that alters the immune response known as immune modulators. Immune modulators can stimulate or inhibit white cell activity or immune response, It is generally suggested in the poor immune systems because of disease like AIDS or rheumatoid arthritis.
The immune-suppressants use in the case of organ transplant to inhibit the white cell activity because it is a chemical agent that inhibits the white cell activity or immune response.
Thus, the immune suppressants are the agent that only inhibit the immune response whereas the immune modulator can stimulate or inhibit the immune response.
